title: Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative.
abstract: The authors retrospectively examined the contralateral prophylactic mastectomy (CPM) rate among 100 women with ductal carcinoma in situ who are BRCA negative. Of 100 women with ductal carcinoma in situ, 31 elected contralateral prophylactic mastectomy (CPM). Factors associated with increased likelihood of undergoing contralateral prophylactic mastectomy (CPM) among this cohort were: family history of ovarian cancer, marital status, reconstruction, mastectomy of the affected breast, and tamoxifen use.
authors.affiliation: 1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Nisreen
authors.initials: N
authors.lastname: Elsayegh
authors.affiliation: 1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Jessica
authors.initials: J
authors.lastname: Profato
authors.affiliation: 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Angelica M Gutierrez
authors.initials: AM
authors.lastname: Barrera
authors.affiliation: 3. Department of Biostatistics, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Heather
authors.initials: H
authors.lastname: Lin
authors.affiliation: 4. Department of Surgical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Henry M
authors.initials: HM
authors.lastname: Kuerer
authors.affiliation: 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Can
authors.initials: C
authors.lastname: Ardic
authors.affiliation: 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Litton
authors.affiliation: 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Debasish
authors.initials: D
authors.lastname: Tripathy
authors.affiliation: 1. Clinical Cancer Genetics, the University of Texas MD Anderson Cancer Center, Houston, TX ; 2. Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Banu K
authors.initials: BK
authors.lastname: Arun
keywords: BRCA negative; contralateral prophylactic mastectomy